Tactile Medical Announces New Appointments to Board of Directors
January 05 2022 - 4:05PM
Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:
TCMD), a medical technology company focused on developing medical
devices for the treatment of patients with underserved chronic
diseases at home, today announced the appointment of Valerie L.
Asbury and D. Brent Shafer to the Company’s Board of Directors
(“Board”), effective January 5, 2022. Ms. Asbury will serve as a
member of both the Audit Committee and the Compliance &
Reimbursement Committee. Mr. Shafer will serve as a member of the
Audit Committee, the Compensation & Organization Committee, and
the Nominating & Corporate Governance Committee. Three
long-standing directors will be retiring from the Board ahead of
the May shareholder meeting: Peter Soderberg, Richard Nigon and
Kevin Roche.
“We are extremely pleased to welcome Valerie and
Brent to our Board; both experienced leaders, adding depth of
expertise in the treatment of chronically ill patients and channels
to access and support them,” said Bill Burke, Chairman of the Board
of Tactile Medical. “I would also like to extend my sincere
gratitude to Peter, Dick and Kevin for their dedicated years of
service. Their counsel and oversight played an important role in
helping Tactile Medical become a successful company, eclipsing $200
million in annual revenue.”
Since 2018, Valerie Asbury has served as the
President and CEO of LifeScan, a global leader in blood glucose
monitoring, serving more than 20 million people with diabetes. Ms.
Asbury previously held a series of leadership roles within Johnson
& Johnson (NYSE: JNJ) for over 20 years from 1998 to 2018,
including executive sales and general management positions. Her
most recent position at Johnson & Johnson was Global President
of Diabetes Solutions from 2013 to 2018, including the Global
LifeScan subsidiary until its sale in October 2018 to Platinum
Equity, a leading private investment firm. She holds a Bachelor of
Science in Nursing from Vanderbilt University.
Brent Shafer most recently served as Chairman
and CEO of Cerner Corporation from 2018 until September 2021, a
global healthcare technology company that was acquired by Oracle
Corporation (NYSE: ORCL) in December 2021. Prior to Cerner, Mr.
Shafer was Chief Executive Officer of Philips North America, a
health technology company and the North American division of
Koninklijke Philips N.V. (“Philips”; NYSE: PHG, AEX: PHIA), from
2014 to 2018. Mr. Shafer also served as Chief Executive Officer of
the global Philips' Home Healthcare Solutions business from 2010
until 2014. Mr. Shafer previously held a series of leadership roles
at Philips, Hill Rom and GE Healthcare. He holds a Bachelor of
Science from the University of Utah.
About Tactile
Medical
Tactile Medical is a leader in developing
and marketing at-home therapies for people suffering from
underserved, chronic conditions including lymphedema, lipedema,
chronic venous insufficiency and chronic pulmonary disease by
helping them live better and care for themselves at home. The
company collaborates with clinicians to expand clinical evidence,
raise awareness, increase access to care, reduce overall healthcare
costs and improve the quality of life for tens of thousands of
patients each year.
Investor Inquiries:
Mike Piccinino, CFA
Managing Director
ICR Westwicke
investorrelations@tactilemedical.com
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Jun 2024 to Jul 2024
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Jul 2023 to Jul 2024